ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,594,075 | +5.4% | 126,602 | +2.2% | 0.00% | 0.0% |
Q2 2023 | $2,462,092 | -17.9% | 123,910 | -29.2% | 0.00% | 0.0% |
Q1 2023 | $2,998,110 | +213.3% | 175,021 | +257.9% | 0.00% | – |
Q4 2022 | $956,973 | +22.7% | 48,900 | 0.0% | 0.00% | – |
Q3 2022 | $780,000 | -65.6% | 48,900 | -70.3% | 0.00% | -100.0% |
Q2 2022 | $2,269,000 | +15.5% | 164,889 | +33.1% | 0.00% | 0.0% |
Q1 2022 | $1,965,000 | -37.4% | 123,900 | -13.8% | 0.00% | 0.0% |
Q4 2021 | $3,139,000 | -29.2% | 143,812 | -3.0% | 0.00% | -50.0% |
Q3 2021 | $4,432,000 | +82.5% | 148,272 | +170.3% | 0.00% | +100.0% |
Q2 2021 | $2,429,000 | +12.2% | 54,847 | +12.4% | 0.00% | 0.0% |
Q1 2021 | $2,165,000 | -17.7% | 48,800 | +1.7% | 0.00% | 0.0% |
Q4 2020 | $2,632,000 | +229.0% | 48,000 | +37.1% | 0.00% | – |
Q3 2020 | $800,000 | +5.0% | 35,000 | -3.8% | 0.00% | – |
Q2 2020 | $762,000 | +56.1% | 36,400 | +4.0% | 0.00% | – |
Q1 2020 | $488,000 | -42.7% | 35,000 | -6.4% | 0.00% | – |
Q4 2019 | $851,000 | +76.9% | 37,400 | -9.4% | 0.00% | – |
Q3 2019 | $481,000 | +4.1% | 41,300 | +34.1% | 0.00% | – |
Q2 2019 | $462,000 | +9.0% | 30,800 | +27.3% | 0.00% | – |
Q1 2019 | $424,000 | +41.8% | 24,200 | +19.8% | 0.00% | – |
Q4 2018 | $299,000 | -19.6% | 20,200 | +33.8% | 0.00% | – |
Q3 2018 | $372,000 | -68.4% | 15,100 | -74.8% | 0.00% | -100.0% |
Q2 2018 | $1,176,000 | – | 59,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |